LGALS3 and congestive heart failure: Several studies, including a recent meta-analysis [4], investigated the outcome prediction of Gal-3 in chronic heart failure, being generally considered a significant predictor for cardiac events even after adjusting for natriuretic peptide levels [5,6,7,8].